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Marine actinobacteria produces diverse array of metabolites with novel chemical structures with potential bioactivities. 
Exploring the understudied ecosystems may increase the chance of getting novel actinobacteria and new metabolites.The 
present study explores the bioactive potential of actinobacteria isolated from the marine ecosystem of Andaman and Nicobar 
Islands, Bay of Bengal, against Mycobacterium tuberculosis and other clinical pathogens. The crude extracts from 15 marine 
actinobacterial strains were produced through agar surface fermentation using YEME agar and extracted using ethyl acetate. 
The crude extracts were tested against the standard strain M. tuberculosis H37Rv, clinical drug sensitive M. tuberculosis, 
and MDR M. tuberculosis strains by luciferase reporter phage (LRP) assay at 500 µg/ml concentration. The anti-microbial 
activity against other clinical pathogens, namely, Staphylococcus aureus, Escherichia coli, Salmonella paratyphi, 
Klebsiellapneumoniae, Pseudomonas aeruginosa, Candida albicans, and Cryptococcusneoformans and non-tubercular 
mycobacteria, M. smegmatis was studied by agar plug method. Among the 15 extracts that were tested for anti-tubercular 
activity, the crude ethyl acetate extract of the 14 actinobacterial strains showed anti-tubercular activity against at least one of 
the three M. tuberculosis strains. Exceptionally, the ethyl acetate extract of strain SACC 168 inhibited all three M. 
tuberculosis strains tested. In anti-microbial screening, the crude extracts of eight strains showed anti-microbial activity 
including six strains, which were active against the non-tuberculous mycobacteria. Further purification and characterization 
of the active molecule from the potential extracts will pave way for the potential natural product candidate for tuberculosis 
and other microbial infections.  
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Introduction 
Tuberculosis (TB) caused by the bacillus 
Mycobacterium tuberculosis is the second most prime 
cause of death worldwide. The World Health 
Organization (WHO, Geneva) has reported almost nine 
million new cases of TB, out of which 1.3 million 
succumb to death1. Further, the emergence of 
multidrug resistant (MDR) as well as extensively drug 
resistant (XDR) among M. tuberculosis strains has 
urged the global scientists to discover novel antibiotics 
for TB. Microbial-derived natural products have a long 
history in the treatment of TB. Among the microbial 
producers of secondary metabolites, actinobacteria (a 
group of gram-positive, filamentous bacteria) are 
supreme secondary metabolite producers2 which show 
a range of biological activities, such as anti-bacterial, 
anti-fungal, anti-cancer, anti-tumor, cytotoxic, 
cytostatic, anti-inflammatory, anti-parasitic, anti-
malaria, anti-viral, anti-oxidant, anti-angiogenesis, and 
so on. Marine-derived actinobacteria are the emerging 
source of novel bioactive metabolites. The marine 
ecosystem in the Andaman and Nicobar Islands is 
mostly an untapped virgin resource and may provide a 
rich source of microorganisms producing novel and 
effectively potent anti-microbial compounds3. 
Actinobacteria from the Andaman marine ecosystems 
are less explored source for bioactive metabolites. To 
our knowledge, only a few studies have been reported 
on the anti-mycobacterial activity of the marine 
actinobacteria from the Andaman and Nicobar 
Islands4,5. Of them, many have been obtained from 
Streptomyces6 and these natural products have been an 
extraordinary source for lead structures in the 
development of new anti-microbial drugs7. With this 
view, the present study was attempted to investigate the 
anti-tubercular activity of actinobacteria isolated from 
the Andaman mangrove sediments. 
 
Methods and Materials 
Isolation of actinobacteria 
Sediment samples were collected from the 
Burmanallah mangrove region in the Andaman 
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Islands (Lat. 11° 39.478; Long. 92°.36.264) and 
dried at room temperature for two days. About 1 g of 
sediment sample was taken and treated at 55 °C in a 
hot air oven for 10 min. The pre-treated sample was 
serially diluted and aliquots from 103 to 105 dilutions 
were plated on Kuster’s agar and starch casein agar 
supplemented with nalidixic acid (20 µg/mL) and 
nystatin (100 µg/mL). All the plates were incubated at 
28 °C for one month. During incubation, colonies 
with suspected actinobacterial morphology were 
recovered using ISP2 agar. Morphologically different 
colonies were selected, subcultured, and maintained 
on ISP2 agar slants at 4 °C until further study8. All the 
media used in this research work were prepared 
using50% seawater. 
 
Characterization of actinobacterial strains 
Cultural and microscopic characteristics of the 
actinobacterial strains were studied by adopting the 
methods described by Shirling and Gottileb9. All the 
actinobacterial strains were cultured on ISP2 agar at 
28 °C for 7–14 days. The recorded characteristics 
include growth level, colony consistency, aerial mass 
color, reverse side pigment, and soluble pigment. The 
micromorphological characteristics were studied by 
slide culture method. The slides were observed under 
a bright field microscope at 40× magnification on the 
14th day of incubation. The micromorphological 
characteristics that were recorded include the 
following: (i) Aerial mycelium, (ii) substrate 
mycelium, and (iii) spore chain morphology. 
 
Bioactive metabolite production 
The bioactive metabolites from actinobacterial 
strains were produced by adopting the agar surface 
fermentation10. The spores of actinobacterial cultures 
were inoculated into every10 plates of yeast extract–
malt extract (YEME) agar and incubated at 28 °C for 
10 days. During incubation, the extracellular 
metabolites were secreted into the agar medium. After 
incubation, the mycelial growth was scrapped using a 
sterile spatula. The agar medium, which contains the 
secreted metabolites, was cut into pieces and 
extracted using ethyl acetate at 1:2 ratio for 24 h. The 
solvent portion was collected and concentrated using 
a rotary evaporator and quantified.  
 
In vitro screening for anti-microbial activity  
The anti-microbial activity was evaluated by disc 
diffusion method against Staphylococcus aureus, 
Escherichia coli, Salmonella paratyphi, 
Klebsiellapneumoniae, Pseudomonas aeruginosa, 
Candida albicans, and Cryptococcus neoformans and 
non-tuberculous mycobacterium (M. smegmatis)11. 
The inoculum of bacterial and fungal cultures with 0.5 
McFarlands standard was prepared using sterile 
nutrient and Sabouraud broth and inoculated onto 
Muller Hinton Agar (MHA). About 10 mg/ml 
concentration of actinobacterial extract was prepared 
as a main stock solution using ethyl acetate and 
filtered using sterile 0.45 µ syringe filter. About 1 
mg/ml of working stock solution was prepared by 
adding 10 µl of the stock extract into 90 µl of ethyl 
acetate solvent and mixed well. Antibiotic discs were 
prepared at 250 µg/disc concentration from working 
extract using 5 mm diameter disc and allowed to dry. 
The extracts-impregnated discs were placed over the 
MHA plates. The zone of inhibition was measured 
after 24 hours of incubation at 37 °C and expressed in 
millimeter in diameter11. 
 
Screening for anti-tubercular activity 
The ethyl acetate extract of 15 actinobacterial 
strains was screened for anti-mycobacterial activity 
by LRP assay12. A reduction of 50% in relative light 
units (RLU) as measured by a luminometer was 
considered as sensitive. The standard laboratory strain 
M. tuberculosis H37Rv, Streptomycin Isoniazid 
Rifampicin Ethambutol (SHRE) sensitive and SHRE-
resistant clinical strains of M. tuberculosis were 
obtained from the Department of Bacteriology, 
National Institute for Research in Tuberculosis 
(NIRT-ICMR), Chennai. The viability of all the 
isolates was maintained on LJ slopes. High titer of 
mycobacteriophage phAE129 used in this study was 
prepared using M. smegmatismc2155 in Middlebrook 
7H9 complete medium13. 
About 350 µL of G7H9 broth supplemented with 
10% albumin dextrose complex and 0.5% glycerol 
was taken in cryo vials and added with 50 µL of crude 
extract to get the final concentration of 100 µg/mL. 
About 100 µL of M. tuberculosis cell suspension was 
added to all the vials. The above procedure was 
followed for all the three M. tuberculosis isolates. 
Dimethyl sulfoxide (1%) was also included in the 
assay as a solvent control. All the vials were 
incubated at 37 °C for 72 hours. After incubation,  
50 µL of high titer phage phAE129 and 40 µL of  
0.1 MCaCl2 solution were added to the test and 
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control vials. All the vials were incubated at 37°C for 
4 h. After incubation, 100 µL from each vial was 
transferred to luminometer cuvette. About 100 µL  
of D-luciferin was added and RLU was measured  
in aluminometer. 
 
Percentage RLU reduction =
Control RLU −  Test RLU
Control RLU
× 100 
 
Results and Discussion 
A total of 15 actinobacterial cultures were isolated 
from the Andaman marine sediments. All the cultures 
produced powdery colonies on ISP2 agar with aerial 
and substrate mycelium formation. Based on the 
morphological features, all the cultures were 
tentatively identified as Streptomyces (Table 1). The 
maximum numbers of actinobacterial colonies were 
observed on Kuster’s agar than in starch casein agar. 
Kuster’s agar is the suitable medium for the isolation 
of mangrove actinobacteria as described in the 
previous studies14,15. 
The present study shows that out of the 15 
actinobacterial strains screened for their anti-
microbial activity, only three ethyl acetate extracts of 
actinobacterial strains showed potent anti-microbial 
activity (>10 mm each) against seven different 
pathogens. The actinobacterial strains, namely, SACC 
164, SACC 162, and SACC179 showed prominent 
activity against the pathogens tested (Table 2). Only 
SACC 96, SACC 161, and SACC 381 were found to 
be active against S. aureus. The strains SACC 96 and 
SACC 162 showed prominent activity against K. 
pneumonia (19 mm) and the strains SACC 168 and 
SACC 179 showed maximum activity against E. coli 
(Table 2). Similarly, the Streptomyces sp. PM-32 
isolated from the sediments collected at the Bay of 
Bengal coast in a previous study has shown anti-
microbial activity against a group of bacterial and 
fungal pathogens16. Our results closely resembled that 
of previous study with the actinobacteria, mostly 
Streptomyces spp. isolated from the mangrove 
sediments of Barmanallha and Carbyn’s Cove of 
South Andaman, by showing anti-bacterial activity 
against the human pathogens17. Our results of anti-
microbial activity show that the mangrove ecosystems 
of South Andaman have high potential actinobacteria 
with bioactivity from which novel compounds can  
be identified.  
The crude extracts that showed more than 50% 
RLU reduction is considered as the anti-
mycobacterial activity. In the present study, the 
culture filtrates from 15 strains of Streptomyces sp. 
inhibited one or more of the M. tuberculosis strains 
tested. Among the 15 ethyl acetate crude extracts, 
eight showed more than 50% inhibition against all the 
three M. tuberculosis strains (Table 2). Out of the 15 
isolates, SACC 387 showed the maximum percentage 
of relative inhibition of anti-mycobacterial activity 
against Mycobacterium tuberculosis H37Rv (93.74%) 
as well as moderate inhibition against Mycobacterium 
all sensitive (85.52%) and MDR (66.72%) (Table 2). 
Marine-derived antibiotics may be more efficient 
against pathogens because the terrestrial bacteria have  
 
Table 1 — Cultural and micromorphology of actinobacterial strains 
Strains 
Cultural characteristics Micromorphology 
Growth Consistency AMC RSP SP AM SM 
SACC 96 Good Powdery Dark gray - - + + 
SACC 161 Good Powdery Whitish gray Golden yellow - + + 
SACC 164 Good Powdery Dark gray Orangish yellow - + + 
SACC 169 Good Powdery Dark gray Brownish yellow - + + 
SACC 162 Good Powdery Dark gray Orangish yellow - + + 
SACC 168 Good Powdery Dark gray Brownish yellow - + + 
SACC 177 Good Powdery Dirty white Pale brown - + + 
SACC 179 Good Powdery Gray Yellow - + + 
SACC 186 Good Rough leathery Dirty yellow Brown black - + + 
SACC 328 Good Powdery Gray Pale yellow -` + + 
SACC 336 Good Powdery Cream Pale yellow Pale green + + 
SACC 369 Good Powdery Cream Yellow - + + 
SACC 374 Good Powdery Creamish white Pale yellow Pale yellow + + 
SACC 381 Good Powdery Gray Brown Brown + + 
SACC 387 Good Powdery White Pale brown - + + 
+, present; -, absent; AMC, aerial mass color; RSP, reverse side pigment; SP, soluble pigment. 
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not developed resistance against them18. The 
actinobacterial strains MSU and ANS2 isolated from 
the marine origin have been reported to exhibit 
promising anti-mycobacterial activity4. The majority 
of ethyl acetate extracts of actinobacteria tested 
showed remarkable anti-mycobacterial activity. Our 
findings clearly demonstrate that marine 
actinobacteria, especially Streptomyces sp., are a good 
source showing prominent activity against 
mycobacterial pathogens. 
Further investigations are needed in order to 
determine the active metabolites. Purification of active 
compounds that selectively act on conserved targets 
may pave the way for highly effective antibiotics. 
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